TY  - GEN
AU  - Shokrollahi Barough,Mahdieh
AU  - Ashtari,Fereshteh
AU  - Sadat Akhavi,Mehdi
AU  - Asghari,Nabiollah
AU  - Mosayebi,Ghasem
AU  - Mirmohammadkhani,Majid
AU  - Kokhaei,Naser
AU  - Bahraminia,Farhad
AU  - Ajami,Arman
AU  - Kokhaei,Parviz
TI  - Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability
SN  - 1878-1705
PY  - 2019///0102
KW  - A549 Cells
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adult
KW  - Antibodies, Neutralizing
KW  - blood
KW  - Biosimilar Pharmaceuticals
KW  - Cell Culture Techniques
KW  - Disability Evaluation
KW  - Persons with Disabilities
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Humans
KW  - Interferon beta-1a
KW  - Multiple Sclerosis, Relapsing-Remitting
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.intimp.2018.06.032
ER  -